AlviArmani Advancements • EXO‑Q™
EXO‑Q™ Exosome Hair Restoration
A qualified exosome protocol designed to support hair growth signaling—where exosome preparations are selected using AlviArmani’s MicroScalp Assay for hair‑relevant biologic activity.
Overview
Exosome therapy is discussed widely—yet exosome products are not biologically interchangeable. EXO‑Q™ is AlviArmani’s protocol framework for qualifying exosome vendors and lots for hair restoration relevance using MicroScalp Technology—then applying qualified preparations within a clinically guided treatment plan.
Part of AlviArmani Advancements • Research through the AlviArmani Research Institute • Start here for the educational hub: Exosomes for Hair Loss
What Is EXO‑Q™?
EXO‑Q™ is AlviArmani’s exosome therapy standard for hair restoration. The “Q” denotes Qualified—meaning preparations are selected from external vendors, but are screened for hair‑relevant biologic signaling using AlviArmani’s internal MicroScalp Assay before they are used in protocol.
- Vendor‑sourced, clinically selected: exosomes are sourced through vetted vendors, then evaluated for relevance.
- Hair‑specific qualification: selection is based on biologic activity patterns relevant to scalp/follicle signaling—not brand claims.
- Protocol‑driven use: applied when clinically appropriate and when follicles remain viable.
For an exosome head to head study at alviarmani research institute, see: Exosomes Hair Growth Study .
How AlviArmani Qualifies Exosomes for Hair Restoration
Exosomes are a signaling tool. Their potential usefulness for hair restoration depends on signal quality, consistency, and biologic activity—which can vary by source, processing, and handling.
- Identify candidate vendors with acceptable manufacturing and handling controls.
- Run head‑to‑head MicroScalp evaluations to assess hair‑relevant signaling patterns under standardized conditions.
- Select qualified preparations that demonstrate consistency in the assay.
- Deploy within protocol based on diagnosis, follicle viability, and treatment goals.
Learn how MicroScalp is used to evaluate biologic preparations in a hair‑relevant context.
EXO‑Q™ focuses on measured biologic behavior—not marketing labels—so the therapy is selected for the purpose of hair restoration.
How EXO‑Q™ Is Used
Standalone non‑surgical option
For early‑to‑moderate thinning where follicles remain viable, EXO‑Q™ may be considered to support hair‑growth signaling as part of a broader plan.
Start with the hub for expectations and timelines: Exosomes for Hair Loss.
Adjunctive to other protocols
In select plans, exosomes may be layered with other modalities (e.g., PRP, mesotherapy‑based delivery, or procedure‑adjacent workflows) when clinically appropriate.
Related: AMP‑T PRP™ • TR6™ Botanical Technology
Candidate profile (high level)
- Most appropriate: early‑to‑moderate thinning with viable follicles
- Less appropriate: areas with complete follicular loss
- Best framed as: supportive therapy within a treatment plan—not a cure
Candidacy is confirmed in consultation with medical review and scalp assessment.
How EXO‑Q™ Compares
| Modality | What it is | Typical role |
|---|---|---|
| EXO‑Q™ | Qualified exosome signaling therapy (vendor‑sourced, MicroScalp‑selected) | Supports signaling context in viable follicles; can be layered into broader plans |
| AMP‑T PRP™ | Autologous platelet‑rich plasma protocol | Supports scalp quality and recovery conditions; often used standalone or peri‑procedure |
| TR6™ | Botanical bioactive technology used within clinical protocols | Supports follicular microenvironment; can be deployed via mesotherapy‑style delivery when appropriate |
Safety, Side Effects, and Oversight
EXO‑Q™ is generally described as minimally invasive when delivered by experienced clinicians. Most effects are localized (temporary tenderness, redness, or swelling). Safety depends on proper handling, sterile technique, and appropriate patient screening.
Common short‑term effects
- Temporary scalp sensitivity
- Mild redness or swelling
- Short‑term tightness at treatment sites
When to pause or discuss first
- Active scalp infection or inflammatory flare
- Complex medical history requiring clearance
- Unclear diagnosis or diffuse shedding without evaluation
Clinical Oversight & Research Legitimacy
EXO‑Q™ qualification standards and MicroScalp evaluation methods are developed and refined through the AlviArmani Research Institute. Treatment planning is physician‑guided and depends on scalp biology, hair‑loss pattern, and follicle viability.
If you want the educational overview with results links and comparisons, start at the hub: Exosomes for Hair Loss. For a exosome hair loss study report see: Exosome Hair Loss Study
Next Steps
If you’re deciding between exosomes, PRP, TR6™, or surgery, a consultation is the fastest way to set expectations and build a plan around your goals.
Frequently Asked Questions
What does “EXO‑Q™” mean?
EXO‑Q™ refers to AlviArmani’s Qualified exosome protocol—where vendor preparations are evaluated using the MicroScalp Assay for hair‑relevant biologic activity before they are used in treatment planning.
Do you manufacture your own exosomes?
No. EXO‑Q™ exosomes are sourced through vetted vendors. AlviArmani’s differentiator is qualification: selecting preparations for hair restoration relevance using MicroScalp Technology.
Are exosomes interchangeable across clinics?
Not necessarily. Exosome preparations can vary by source and processing. EXO‑Q™ is designed to reduce variability by qualifying preparations in a hair‑relevant assay context.
Can EXO‑Q™ be combined with PRP or TR6™?
In select plans, yes. Combination strategies may be considered when clinically appropriate. Related protocol pages: AMP‑T PRP™ and TR6™.